Hepatitis B vaccination efforts in the United States are entering a renewed phase as public health authorities intensify strategies to close immunization gaps and prevent long-term liver disease. With updated clinical guidance, expanded adult vaccination recommendations, and growing employer- and pharmacy-led initiatives, the focus has shifted from risk-based coverage to broader population protection. Health agencies are emphasizing early prevention to curb rising cases linked to chronic infections, migration patterns, and uneven vaccine uptake.